BIRC5 and gastric adenocarcinoma: Several studies on thyroid carcinoma (THYR) cell lines demonstrate the involvement of Survivin in inhibiting cell proliferation [71–73] and an in vivo study using human gastric adenocarcinoma cell lines in mice xenografts showed that inhibition of Survivin expression could promote cell death [74].